LGD-4033 + RAD-140 (8 weeks)
A representative non-steroidal SARM stack.
Concentration over time
| Date | Testolone (RAD-140) | Ligandrol (LGD-4033) |
|---|---|---|
| W1 | 0.00 | 0.00 |
| W1 | 1389.37 | 831.89 |
| W2 | 1479.82 | 1068.36 |
| W2 | 1463.22 | 744.30 |
| W3 | 1426.25 | 900.01 |
| W4 | 1384.87 | 1087.83 |
| W4 | 1343.19 | 755.22 |
| W5 | 912.90 | |
| W6 | 1103.35 | |
| W6 | 766.04 | |
| W7 | 925.97 | |
| W8 | 1119.02 | |
| W8 | 777.01 |
Protocol summary
LGD-4033 + RAD-140 (8 weeks) · 8 weeks starting Jul 20, 26
- Ligandrol (LGD-4033) — 5.00 mg Every day, weeks 0–8
- Testolone (RAD-140) — 10.0 mg Every day, weeks 0–8
Protocol overview
- Category
- aas cycle
- Duration
- 8 weeks
- Compounds
- 2
- Tags
- sarms, lgd, rad
Compounds in this protocol
- Ligandrol (LGD-4033) — 5 mg, every-day
- Testolone (RAD-140) — 10 mg, every-day
How to read this protocol
The chart above shows the modeled blood concentration of each compound over the 8-week duration. Each compound accumulates toward steady state (roughly 5 half-lives). The peak-to-trough ratio within each dose interval depends on the injection frequency relative to the half-life.
Use the [peak-trough estimator](/tools/peak-trough) to see predicted levels at any point, or the [clearance calculator](/tools/clearance) to estimate washout after the protocol ends. The [PCT planner](/pct-planner) estimates when to start post-cycle therapy.
Educational only. Not medical advice. Concentration values are modeled estimates based on population pharmacokinetics, not predictions of individual blood levels.